The current status of biomarkers for predicting toxicity.
about
Predictive biomarkers for treatment selection: statistical considerationsmicroRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentPharmacologic biomarkers in the development of stratified cancer medicine.The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse.Industry perspectives on biomarker qualification.Cell- and biomarker-based assays for predicting nephrotoxicity.Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology.Gene Expression Patterns Associated With Histopathology in Toxic Liver Fibrosis.MicroRNAs and toxicology: A love marriage.Evaluation of miR-216a and miR-217 as Potential Biomarkers of Acute Exocrine Pancreatic Toxicity in Rats.Identification of aldo-keto reductase (AKR7A1) and glutathione S-transferase pi (GSTP1) as novel renal damage biomarkers following exposure to mercury.Current practices and future outlook on the integration of biomarkers in the drug development process.A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.Exposure assessment of natural uranium from drinking water.Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin.Single Oral Acute Toxicity of Banhasasim-Tang and Its Antiobesity Effect on Diet-Induced Obese Mice and 3T3-L1 Adipocytes
P2860
Q26778367-D60ECD1B-023B-47BE-8333-031BFDF6B6A0Q26778918-24765CA3-66E2-4DAC-A862-F109E5DEE691Q33626476-8EAFB244-56FC-479E-834E-F69B6CEB14C6Q35881677-22E79401-CF73-474F-8384-9F5D5B65A719Q37341324-2F543589-D2F7-452A-ABDB-79D0473D1F25Q38266417-B5E886DA-C8CD-4078-B632-E623BDB6BA25Q38831928-6563ABEE-5044-4059-9649-706C7296158CQ40512525-2C4477ED-C67C-457A-9B1B-ABFA169A1A53Q45352157-E247E4A2-EBB6-4D84-987D-4C55E80BE245Q46788854-685835C8-E830-4312-9052-219FDB403AB9Q47234835-084B8F77-959E-4AFA-8756-562FFC76FBB2Q47626694-FC3F8C20-4330-46FB-9C8B-BC2A789A0FF2Q49873286-4950082E-C3C8-46FF-BF96-81181747268FQ51052275-C3F724C1-7B56-49D2-B806-D580A541A154Q52596252-7968F1A3-ACBC-4EAE-90D8-7853AC758C76Q58693470-EE274AD1-8A1E-4FCD-87C4-3CBDC3073FD6
P2860
The current status of biomarkers for predicting toxicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The current status of biomarkers for predicting toxicity.
@en
The current status of biomarkers for predicting toxicity.
@nl
type
label
The current status of biomarkers for predicting toxicity.
@en
The current status of biomarkers for predicting toxicity.
@nl
prefLabel
The current status of biomarkers for predicting toxicity.
@en
The current status of biomarkers for predicting toxicity.
@nl
P2093
P2860
P1476
The current status of biomarkers for predicting toxicity.
@en
P2093
David W Brewster
Deborah Burt
Federico Goodsaid
Janani Saikumar
Jiri Aubrecht
Kathleen Hwang
Kim Boekelheide
Linnea Anderson
Mark Sigman
Sara Pacheco
P2860
P304
P356
10.1517/17425255.2013.827170
P407
P50
P577
2013-08-21T00:00:00Z